![Akiko Futamura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Akiko Futamura is currently the President & Chief Executive Officer at Hinge Therapeutics, Inc. Prior to this, she was the President & Director at CarnaBio USA, Inc.
| Società | Posizione | Inizio |
|---|---|---|
Hinge Therapeutics, Inc.
 Hinge Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops novel drugs through artificial intelligence | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
CarnaBio USA, Inc.
 CarnaBio USA, Inc. Medical DistributorsDistribution Services Wholesales kinases protein, substrates and biotinylates kinases products | Presidente | 01/02/2019 |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 2 |
|---|---|
CarnaBio USA, Inc.
CarnaBio USA, Inc. Medical DistributorsDistribution Services Wholesales kinases protein, substrates and biotinylates kinases products | Distribution Services |
Hinge Therapeutics, Inc.
Hinge Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops novel drugs through artificial intelligence | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
